Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 3, 2026 · Leadership change · Financial statements
Cadrenal Therapeutics, Inc.
7
Leadership change
Jun 3, 2026
| Item 5.02 | Director or executive officer departure or appointment |
| Item 9.01 | Financial statements and exhibits |
Cadrenal Therapeutics, Inc. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
) 822 A1A North , Suite 306 Ponte Vedra , Florida 32082 (Address of principal executive offices and zip code) ( 904 ) 300-0701 (Registrant’s telephone number including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions ( see General Instruction A. below): ☐ Written communications pursuant to Rule 425 under the Securities Act…
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Cadrenal Therapeutics, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
